A CRYSTALLINE VARIABLE HYDRATE OF (S)-6-(4-(2-((3-(9H-CARBAZOL-4-YLOXY)-2-HYDROXYPROPYL)AMINO)-2-METHYLPROPYL)PHENOXY)-3-PYRIDINICARBOX AMIDE HEMISUCCINATE SALT

摘要

The present invention relates to a crystalline variable hydrate of (S)-(3- pyridinecarboxamide,6-[4-[2-[[3-(9H-carbazol-4-yloxy)-2-hydroxypropyl]amino]-2-methylpropyl]phenoxy])-hemi-succinate, a pharmaceutical formulation containing said salt and to methods for treating obesity and/or Type 2 diabetes using said salt.